ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 241

$9.2M Total Retail Price of All Prescriptions

Rank: 1 out of 241

1,885 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 1,885 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 12,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$452 was the average price of a prescription from this provider, compared to $175 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,315 604 S3 1 3
TRAMADOL HCL 1,302 822 2 5
LYRICA 1,279 805 10 3 12
VOLTAREN 1,183 790 10 4 19
HYDROXYCHLOROQUINE SULFATE 1,128 745 5 4
SULFASALAZINE 1,113 679 10 6 20
LIDODERM 1,072 706 7 27
METHOTREXATE 919 538 8 2
ORENCIA 818 586 10 9 38
FORTEO 776 672 10 10 37
GABAPENTIN 752 455 11 6
CYMBALTA 561 271 12 11
ATELVIA 539 385 13 25
ENBREL 535 281 10 14 10
CELEBREX 465 272 15 13
HUMIRA 462 211 10 16 14
DOXYCYCLINE HYCLATE 453 210 17 51
LEFLUNOMIDE 381 211 18 8
BONIVA 372 295 10 19 74
MELOXICAM 330 170 20 7
PEN NEEDLE 319 273 21 69
ALLOPURINOL 268 201 22 16
REMICADE 233 113 10 23 56
LEVOTHYROXINE SODIUM 233 151 23 21
CIMZIA 232 98 10 25 71
SULFAZINE 218 153 10 26 70
ACTONEL 201 133 27 42
IBANDRONATE SODIUM 198 121 28 77
ACETAMINOPHEN-CODEINE 182 95 S3 29 52
ZOLPIDEM TARTRATE 175 69 30 18
ULORIC 159 112 31 44
CYCLOBENZAPRINE HCL 134 45 R 32 15
TRAMADOL HCL-ACETAMINOPHEN 121 73 33 22
COLCRYS 111 59 34 33
AMITRIPTYLINE HCL 101 61 R 35 39
PREDNISONE 89 34 36 1
ACTEMRA 80 47 10 37 143
NEXIUM 73 38 38 31
PROLIA 70 60 39 107
SAVELLA 67 32 40 58
EVOXAC 51 34 41 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.